An Intermediate Size Expanded Access Protocol of AMX0035 for ALS
Public ClinicalTrials.gov record NCT05286372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Intermediate Size, Expanded Access Protocol to Provide AMX0035, a Fixed Combination of Sodium Phenylbutyrate (PB) and Taurursodiol (TURSO), for the Treatment of Adult Patients With Amyotrophic Lateral Sclerosis (ALS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Expanded Access Program will provide access and assess the safety of AMX0035 for the treatment of people living with ALS.
Study identification
- NCT ID
- NCT05286372
- Recruitment status
- Approved For Marketing
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Oct 18, 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033 | — |
| The Kaiser Permanente Medical Group | Oakland | California | 94612 | — |
| Nova Southeastern University | Fort Lauderdale | Florida | 32608 | — |
| Holy Cross Health | Fort Lauderdale | Florida | 33308 | — |
| University of Florida | Gainesville | Florida | 32608 | — |
| Northwestern University | Chicago | Illinois | 60614 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66103 | — |
| The Sean M. Healey & AMG Center for ALS Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Neurology Associates, P.C. / Somnos Clinical Research | Lincoln | Nebraska | 68510 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University Weinberg ALS Center | Philadelphia | Pennsylvania | 19107 | — |
| Texas Tech University Health Sciences Center El Paso | El Paso | Texas | 79995 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Swedish Neuroscience Institute | Seattle | Washington | 98122 | — |
| University of Washington School of Medicine | Seattle | Washington | 98195 | — |
| Providence St. Luke's Rehabilitation Medical Center | Spokane | Washington | 99202 | — |
| University of Wisconsin | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05286372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 18, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05286372 live on ClinicalTrials.gov.